A Study to Test the Long-term Safety, Tolerability and Efficacy of Brivaracetam in Study Participants 2 to 26 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

Childhood Absence Epilepsy Clinical Trial

Official title:
A Multicenter, Open-Label, Single-Arm Study to Evaluate Long-Term Safety, Tolerability, and Efficacy of Brivaracetam in Study Participants 2 to 26 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

Status Enrolling by invitation

Clinical Trial Summary

The purpose of the study is to investigate the long-term safety, tolerability and efficacy of brivaracetam in pediatric study participants with childhood absence epilepsy (CAE) or juvenile absence epilepsy (JAE).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05109234
Study type	Interventional
Source	UCB Pharma
Contact
Status	Enrolling by invitation
Phase	Phase 3
Start date	March 30, 2022
Completion date	September 27, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00393666` - Why Are Patients With Absence Seizures Absent? A Brain Imaging Study	N/A
Terminated	`NCT06153186` - Flunarizine for Treatment Resistant Absence Epilepsy	Phase 2
Not yet recruiting	`NCT06315322` - A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy	Phase 3
Recruiting	`NCT04666610` - A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy	Phase 3
Completed	`NCT00088452` - Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study	Phase 3
Terminated	`NCT03355300` - Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures	Phase 2
Terminated	`NCT03336242` - Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures	Phase 2
Completed	`NCT00361010` - A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy	N/A
Completed	`NCT00041951` - Search for Genes Influencing Childhood Absence Epilepsy (CAE) Study	N/A
Recruiting	`NCT06310772` - Assessing Comorbidities in Epilepsy Using Eye Movement Recordings